Molbio Diagnostics Limited (BOM:544866)
1,312.65
-48.75 (-3.58%)
At close: Sep 16, 2026
Molbio Diagnostics Market Cap
Molbio Diagnostics has a market cap or net worth of 150.62 billion as of September 16, 2026.
Market Cap
150.62B
Enterprise Value
152.81B
Revenue
17.54B
Ranking
n/a
PE Ratio
60.48
Stock Price
1,312.65
ChartMarket Cap Chart
Since August 17, 2026, Molbio Diagnostics's market cap has increased from 120.05B to 150.62B, an increase of 25.47%. That is a compound annual growth rate of 1,480.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 150.62B | -3.67% |
| Sep 15, 2026 | 156.36B | -5.66% |
| Sep 11, 2026 | 165.74B | -4.72% |
| Sep 10, 2026 | 173.94B | 19.99% |
| Sep 9, 2026 | 144.96B | 12.56% |
| Sep 8, 2026 | 128.78B | -0.86% |
| Sep 7, 2026 | 129.90B | -2.87% |
| Sep 4, 2026 | 133.74B | 2.23% |
| Sep 3, 2026 | 130.82B | 2.47% |
| Sep 2, 2026 | 127.66B | 5.17% |
| Sep 1, 2026 | 121.38B | -3.04% |
| Aug 31, 2026 | 125.19B | -0.77% |
| Aug 28, 2026 | 126.16B | -4.32% |
| Aug 27, 2026 | 131.85B | -7.64% |
| Aug 26, 2026 | 142.77B | 0.94% |
| Aug 25, 2026 | 141.44B | 2.34% |
| Aug 24, 2026 | 138.21B | 9.18% |
| Aug 21, 2026 | 126.59B | 5.96% |
| Aug 20, 2026 | 119.46B | - |
| Aug 19, 2026 | 119.46B | -6.68% |
| Aug 18, 2026 | 128.02B | 6.64% |
| Aug 17, 2026 | 120.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 169.63B |
| Choice International | 169.05B |
| BEML Limited | 168.58B |
| Deepak Fertilisers And Petrochemicals Corporation | 166.69B |
| Indigrid Infrastructure Trust | 165.65B |
| Vardhman Textiles | 164.23B |
| Jubilant Pharmova | 162.36B |
| Punjab & Sind Bank | 161.64B |